101 related articles for article (PubMed ID: 10438416)
1. Parenteral administration of progestin Nestorone to lactating cynomolgus monkeys: an ideal hormonal contraceptive at lactation?
Heikinheimo O; Ranta S; Moo-Young A; Lähteenmäki P; Gordon K
Hum Reprod; 1999 Aug; 14(8):1993-7. PubMed ID: 10438416
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women.
Massai MR; Díaz S; Quinteros E; Reyes MV; Herreros C; Zepeda A; Croxatto HB; Moo-Young AJ
Contraception; 2001 Dec; 64(6):369-76. PubMed ID: 11834236
[TBL] [Abstract][Full Text] [Related]
3. Ovarian function during use of Nestorone(R) subdermal implants.
Brache V; Massai R; Mishell DR; Moo-Young AJ; Alvarez F; Salvatierra AM; Cochon L; Croxatto H; Robbins A; Faundes A
Contraception; 2000 Mar; 61(3):199-204. PubMed ID: 10827334
[TBL] [Abstract][Full Text] [Related]
4. Vaginal rings for contraception in lactating women.
Massai R; Díaz S; Jackanicz T; Croxatto HB
Steroids; 2000; 65(10-11):703-7. PubMed ID: 11108880
[TBL] [Abstract][Full Text] [Related]
5. Progestin-only methods safe during lactation.
Netw Res Triangle Park N C; 1993 Oct; 14(2):32-3. PubMed ID: 12287157
[TBL] [Abstract][Full Text] [Related]
6. The progestin ST 1435--rapid metabolism in man.
Heikinheimo O; Noe G; Haukkamaa M; Lähteenmäki P
Contraception; 1994 Sep; 50(3):275-89. PubMed ID: 7805378
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraception and lactation.
Kelsey JJ
J Hum Lact; 1996 Dec; 12(4):315-8. PubMed ID: 9025449
[TBL] [Abstract][Full Text] [Related]
9. Ovarian function during use of vaginal rings delivering three different doses of Nestorone.
Brache V; Mishell DR; Lahteenmaki P; Alvarez F; Elomaa K; Jackanicz T; Faundes A
Contraception; 2001 May; 63(5):257-61. PubMed ID: 11448466
[TBL] [Abstract][Full Text] [Related]
10. Correlation of endocrine profiles with bleeding patterns during use of Nestorone contraceptive implants.
Faúndes A; Alvarez F; Brache V; Cochón L; Tejada AS; Moo-Young A
Hum Reprod; 1999 Dec; 14(12):3013-7. PubMed ID: 10601089
[TBL] [Abstract][Full Text] [Related]
11. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
Fraser IS; Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Tsong YY; Sivin I
Contraception; 2005 Jul; 72(1):40-5. PubMed ID: 15964291
[TBL] [Abstract][Full Text] [Related]
12. Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies.
Kumar N; Fagart J; Liere P; Mitchell SJ; Knibb AR; Petit-Topin I; Rame M; El-Etr M; Schumacher M; Lambert JJ; Rafestin-Oblin ME; Sitruk-Ware R
Endocrinology; 2017 Jan; 158(1):170-182. PubMed ID: 27824503
[TBL] [Abstract][Full Text] [Related]
13. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.
Ilani N; Roth MY; Amory JK; Swerdloff RS; Dart C; Page ST; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Wang C
J Clin Endocrinol Metab; 2012 Oct; 97(10):3476-86. PubMed ID: 22791756
[TBL] [Abstract][Full Text] [Related]
14. An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.
Fraser IS; Weisberg E; Kumar N; Kumar S; Humberstone AJ; McCrossin L; Shaw D; Tsong YY; Sitruk-Ware R
Contraception; 2007 Dec; 76(6):432-8. PubMed ID: 18061700
[TBL] [Abstract][Full Text] [Related]
15. New IPPF statement on breastfeeding, fertility and post-partum contraception.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
[TBL] [Abstract][Full Text] [Related]
16. Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women.
Sivin I; Croxatto H; Bahamondes L; Brache V; Alvarez F; Massai R; Schechter J; Ranta S; Kumar N; Wu E; Tejeda AS; Reyes V; Travers E; Allen A; Moo-Young A
Contraception; 2004 Feb; 69(2):137-44. PubMed ID: 14759619
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive implants and lactation.
Díaz S
Contraception; 2002 Jan; 65(1):39-46. PubMed ID: 11861054
[TBL] [Abstract][Full Text] [Related]
18. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
Jensen JT; Edelman AB; Chen BA; Archer DF; Barnhart KT; Thomas MA; Burke AE; Westhoff CL; Wan LS; Sitruk-Ware R; Kumar N; Variano B; Blithe DL
Contraception; 2018 May; 97(5):422-427. PubMed ID: 29409834
[TBL] [Abstract][Full Text] [Related]
19. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
Laurikka-Routti M; Haukkamaa M
Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
[TBL] [Abstract][Full Text] [Related]
20. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
Mahabadi V; Amory JK; Swerdloff RS; Bremner WJ; Page ST; Sitruk-Ware R; Christensen PD; Kumar N; Tsong YY; Blithe D; Wang C
J Clin Endocrinol Metab; 2009 Jul; 94(7):2313-20. PubMed ID: 19366848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
